PALISADE BIO, INC. — Director's Dealing 2023

Jun 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2023-06-12

Reporting Person: Finley John David (Director, CEO, CFO, Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-12	Common Stock, par value $0.01	M	3475	$0.00	Acquired	7323	Direct
2023-06-13	Common Stock, par value $0.01	F	1050	$1.5415	Disposed	6273	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-12	Restricted Stock Units	$	M	3475	Disposed		Common Stock (3475)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01	777	Indirect

Footnotes

F1: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F2: Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units.

F3: Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.

F4: This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on June 12, 2023, upon receipt of shareholder approval of the grant, and an additional 38,225 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.